Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 31, 2013. The report details a specific share repurchase transaction executed on October 30, 2013, under authority granted by shareholders at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It focuses exclusively on capital structure and share repurchase activity.
- Shares Purchased: 121,500 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,651.50 pence per share; lowest was 1,638.50 pence per share.
- Treasury Holdings (Settled): 507,662,912 shares (9.45% of total issued share capital).
- Treasury Holdings (Including Unsettled): 508,016,412 shares (10.45% of total voting rights).
- Shares in Issue (Excluding Treasury): 4,862,559,738 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 121,500 shares on October 30, 2013. Consequently, the total number of shares held in Treasury increased, raising the percentage of total voting rights held in Treasury to 10.45% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Conduct Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Investor Verification Checklist
- Verify the total number of shares in issue (4,862,559,738) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the current percentage of voting rights held in Treasury (10.45% including unsettled shares).
- Review the price paid per share (1,638.50 to 1,651.50 pence) against market prices on October 30, 2013.
- Note that this filing does not contain operational or financial performance data for the period.